Valye reports for unlimited access

QuoteMedia, Inc. is a provider of financial data, market research, analytics, news feeds, and financial software solutions. Incorporated in 1999 and headquartered in Arizona, the company offers a broad range of products and services to financial institutions, brokerages, media portals, and individual investors. Its offerings include streaming real-time market data feeds, interactive web content and data APIs, and portfolio management systems delivered primarily via SaaS. The company emphasizes technological advancement, low latency data delivery, and custom development capabilities. QuoteMedia’s products cover a wide array of market data including equities, options, futures, commodities, currencies, mutual funds, ETFs, and indices, with global exchange coverage. The company’s client base is diverse, spanning online brokerages, banks, media companies, and public corporations. QuoteMedia operates primarily in North America, with a significant portion of revenue from Canada. The company’s financials show quarterly revenue of $5.53 million and a net loss of $620,612 for Q1 2026, with liquidity ratios indicating a working capital deficit but sufficient cash to fund near-term operations.

New Providence Acquisition Corp. III is a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands in December 2024. The company’s purpose is to identify and complete a business combination with one or more target businesses in any industry. It completed its IPO on April 25, 2025, issuing over 30 million units and raising approximately $301.65 million, which are held in a trust account. The company has not generated operating revenues and does not expect to do so until after consummating its initial business combination. The management team is experienced in acquisitions and is currently pursuing a business combination with Abra, including plans to re-domicile to Delaware and merge Abra as a wholly owned subsidiary. The company must complete its business combination by April 25, 2027, or liquidate and return funds to shareholders. The company’s securities are listed on Nasdaq under multiple ticker symbols representing shares, units, and warrants.

First Tracks Biotherapeutics, Inc. is a newly independent biotherapeutics company spun off from AnaptysBio, Inc. in April 2026. The company acquired assets related to the First Tracks Biotherapeutics Business, including intellectual property, laboratory equipment, and employee contracts. It maintains collaborations such as with Vanda Pharmaceuticals for the development and commercialization of imsidolimab, retaining rights to milestone payments. The company operates with support from a Transition Services Agreement with AnaptysBio to ensure continuity post-spin-off. As of the first quarter of 2026, the company reported a net loss and holds substantial cash reserves, reflecting its early-stage development status.

Elvictor Group, Inc. is a Nevada-incorporated company focused on providing crew and ship management services globally. It manages a diverse workforce of over 2,000 seafarers across bulk carriers and tankers, offering services such as recruitment, training, travel arrangements, and compliance with maritime and data privacy regulations. The company operates through wholly owned subsidiaries in Greece and Cyprus and acquired Ultra Shipmanagement, Inc. to enhance its ship management capabilities. Elvictor recognizes revenue primarily from long-term contracts and competes by leveraging its access to seafarer markets, operational flexibility, proprietary crew management platform, and public company transparency. It is subject to various regulatory frameworks and maintains a robust cybersecurity program overseen by its Board. Financially, as of Q1 2026, the company reported revenues near $1 million and net income of approximately $135,000, with liquidity ratios reflecting current liabilities exceeding current assets.

Vivakor, Inc. is a Nevada-based integrated midstream energy company providing crude oil transportation, terminaling, marketing, and remediation services primarily in the Permian, Eagle Ford, and Anadarko basins. The company operates a large independent trucking fleet, pipeline infrastructure including the Omega Gathering Pipeline, and strategically located terminaling and storage facilities supported by long-term contracts with minimum volume commitments. Its marketing and trading segment manages commodity purchases and sales, leveraging its transportation and terminaling network. The remediation segment, currently under development, focuses on processing oilfield waste to recover hydrocarbons and provide environmental solutions. Vivakor’s business model integrates these segments to capture margin across the crude oil value chain and expand service offerings. The company faces operational, financial, and market risks typical of midstream energy firms, including customer concentration, geographic concentration, regulatory changes, and liquidity constraints.

NVIDIA Corporation develops and sells accelerated computing platforms that combine high-performance GPUs, CPUs, DPUs, and networking components with a broad software stack including CUDA, AI models, and domain-specific frameworks. The company targets four primary markets: Data Center, Gaming, Professional Visualization, and Automotive. Its Data Center segment provides infrastructure for AI training and inference, scientific computing, and networking, featuring architectures such as Blackwell and Rubin. The Graphics segment offers GPUs for gaming and professional visualization, leveraging AI-enhanced rendering technologies. NVIDIA's automotive solutions include AI hardware and software platforms for autonomous and electric vehicles under the DRIVE brand. The company operates a fabless manufacturing model, relying on leading foundries and contract manufacturers. NVIDIA's customer base includes major cloud providers, AI model makers, OEMs, and system integrators. The company maintains a large developer community and invests heavily in R&D to sustain technology leadership.

KonaTel, Inc. is a telecommunications company providing cellular products and services nationwide primarily through its subsidiaries Apeiron Systems and IM Telecom. Apeiron Systems offers a suite of cloud-based communications platform services (CPaaS) including voice, messaging, and network connectivity, while IM Telecom operates as an FCC licensed Eligible Telecommunications Carrier distributing subsidized mobile voice and data services under the Lifeline and formerly the ACP programs. The company sources wireless services from major national carriers and wholesalers and distributes its services through multiple channels including direct sales and independent sales organizations. KonaTel has undergone several mergers and acquisitions to expand its service offerings and currently operates with a relatively small employee base. The company faces regulatory risks related to FCC programs, competitive pressures from larger carriers and resellers, and operational risks including supply chain and cybersecurity challenges. Financially, KonaTel reported revenues of approximately $1.9 million and a net loss for the quarter ended March 31, 2026, with liquidity ratios below 1 indicating potential short-term financial constraints.

Nordson Corporation is a diversified industrial company operating primarily in three segments: Industrial Precision Solutions (IPS), Medical and Fluid Solutions (MFS), and Advanced Technology Solutions (ATS). The company designs, manufactures, and markets precision dispensing equipment, fluid management systems, and advanced technology products serving various industries including packaging, medical, electronics, and industrial coatings. Nordson's revenue recognition is based on short-term fixed-price contracts with revenue recognized at shipment or transfer of control. The company maintains a strong liquidity position supported by cash, current assets, and a $1.2 billion revolving credit facility. Nordson actively manages risks related to cybersecurity and global trade policies. The company has a history of acquisitions, divestitures, and share repurchases, with goodwill tested annually for impairment and no impairments recorded in 2025 [S1][S2].

Aditxt, Inc. is a biotechnology company incorporated in 2017, engaged in developing innovative therapies and diagnostic technologies. Its product pipeline includes ADI-100, a therapy that has advanced to human clinical trials as of early 2026. The company also has a subsidiary, Pearsanta, which acquired patents related to early cancer detection. Aditxt has not yet achieved significant commercial revenue and operates with ongoing net losses. The company’s financial position is strained, with low liquidity ratios and substantial current liabilities. It is subject to regulatory approval processes and competitive pressures typical of the biotech sector.

Cosmos Health Inc. operates as a diversified healthcare group with a vertically integrated business model encompassing research and development, manufacturing, marketing, sales, and distribution of pharmaceutical and nutraceutical products. The company’s pharmaceutical portfolio includes generic medicines across multiple therapeutic areas, proprietary nutraceutical brands such as Sky Premium Life® and Mediterranation®, and biocides with antimicrobial properties. Manufacturing facilities are certified under European GMP and EMA standards, supporting production of a broad range of healthcare products. Distribution leverages advanced robotic technologies to ensure accuracy and efficiency. The company also offers telehealth services through its ZipDoctor platform and utilizes an AI-driven drug repurposing platform, Cloudscreen®, to identify new therapeutic applications for existing drugs. Geographically, Cosmos Health generates most revenues from the EU and UK, with expanding presence in the UAE and North America. The company pursues growth through expanding proprietary brands, optimizing generics, enhancing manufacturing capabilities, and expanding global distribution networks.

Ralph Lauren Corporation is a publicly traded company known for its apparel and lifestyle products. The company reported fiscal year 2026 financial results with revenues exceeding $8 billion and net income nearing $1 billion. It maintains strong liquidity with a current ratio above 2 and a cash ratio above 1 as of the fiscal year end. Recent quarterly results indicate positive earnings and revenue performance, supported by multiple news reports and SEC filings.

REGO Payment Architectures, Inc. is a Delaware-based company providing a mobile payment platform called Mazoola®, designed to enable minors, especially under 13, to transact and learn financial management under parental oversight. The platform is compliant with COPPA and GDPRkids™ Trustmark standards, emphasizing privacy and security. REGO targets financial institutions, FinTech firms, and other partners for licensing and white-labeling its technology. The company aims to serve digital-native generations (Gen Z and Gen Alpha) and has expanded offerings to include elder financial management tools. Revenue streams include subscriptions, transaction fees, licensing, data analytics, and advertising. As of Q1 2026, the company has limited revenue and significant net losses, with a small employee base and outsourced development and marketing.

TruGolf Holdings, Inc. is a virtual golf technology company headquartered in Utah, USA. It develops and markets golf simulation products and services, including hardware and software solutions for golf enthusiasts and commercial operators. The company operates a franchising model under the TruGolf Links brand and has expanded its footprint with new franchise locations. TruGolf integrates advanced technologies such as AI to enhance its product offerings, exemplified by its acquisition of AI firm mlSpatial and the introduction of AI coaching features. The leadership team has deep experience in gaming and technology sectors, supporting the company's innovation and growth strategies.

Greenway Technologies, Inc. develops proprietary GTL synthesis gas conversion systems and modular micro-plants scalable to meet specific gas field production needs. Its patented G-Reformer unit converts various natural gas streams into syngas, which is then processed via Fischer-Tropsch reactors to produce cleaner fuels such as gasoline, diesel, jet fuel, methanol, and high-value chemicals. The company aims to commercialize and license this technology primarily in the U.S. market. The technology enables smaller, transportable GTL plants with lower costs and footprints compared to traditional large-scale refinery plants. Greenway holds multiple patents and has an exclusive licensing agreement with the University of Texas at Arlington. The company is in the development stage with no current revenues and faces liquidity and going concern challenges.

ASP Isotopes Inc. is a publicly traded company on Nasdaq (ASPI) headquartered in Dallas, Texas. The company focuses on the production of helium and the development of advanced nuclear fuels through its subsidiary Quantum Leap Energy LLC. ASP Isotopes completed the acquisition of Renergen Limited, a helium project operator, with strong shareholder approval. The company has raised capital through multiple registered direct offerings to support its growth initiatives. The leadership team includes founder and CEO Paul E. Mann, who has extensive experience in healthcare and chemicals investment. The board of directors includes members with significant expertise in nuclear energy, finance, and strategic governance. Financially, ASP Isotopes reported Q1 2026 revenue of $4.18 million and a net loss of $7.12 million, with a strong liquidity position and a current ratio of 4.39, indicating solid short-term financial health.

Lifeward Ltd. designs, develops, and commercializes medical devices focused on physical rehabilitation and recovery. Its flagship products are robotic exoskeletons, including the ReWalk Personal and Rehabilitation Exoskeletons for individuals with spinal cord injury, enabling ambulatory functions such as standing and walking. The ReWalk 7 model and stair/curb functionality have received FDA 510(k) clearance. The company also markets the ReStore Exo-Suit for stroke rehabilitation and distributes AlterG Anti-Gravity systems acquired in 2023, which use NASA-derived technology to reduce gravity effects during rehabilitation. Lifeward sells primarily in the US and Europe, through direct sales and distributors, and generates revenue from product sales, extended warranties, and repair services. The company has expanded its neurorehabilitation platform through acquisitions, including Oratech and Skelable technology assets. Lifeward operates under complex regulatory frameworks including FDA QMSR and EU MDR, with ongoing compliance and inspection requirements.

IP Strategy Holdings, Inc. is a diversified company operating primarily in digital asset-based infrastructure and intellectual property management, centered on the Story Network blockchain and its native $IP Token. The company acquired 53.2 million $IP Tokens in 2025 and operates validator nodes to stake these tokens, generating staking rewards and commissions from third-party delegations. The company’s treasury reserve policy focuses on accumulating and staking $IP Tokens, with oversight by a Technology and Cryptocurrency Committee. The staking program involves operational risks such as validator slashing and liquidity constraints due to token deactivation periods. Alongside its digital asset business, IP Strategy Holdings maintains a craft spirits segment through Heritage Distilling Company, which produces award-winning craft whiskeys and flavored spirits. The spirits business has shifted to an asset-light model emphasizing premium products, direct-to-consumer sales, wholesale distribution, and expansion of the Tribal Beverage Network in collaboration with Native American tribes. The company faces competitive and regulatory challenges in the spirits industry. Financial disclosures indicate significant operating losses and liquidity pressures, with ongoing efforts to manage cash flow and capital resources.

20/20 Biolabs, Inc. is a diagnostics company focused on developing and commercializing AI-powered, laboratory-based blood tests for early detection and prevention of cancers and chronic diseases. Its primary products are marketed under the OneTest brand, including OneTest for Cancer, a multi-cancer early detection (MCED) test based on protein tumor markers, and OneTest for Longevity, which measures inflammatory biomarkers related to chronic disease risk. The company operates a CAP-accredited, CLIA-licensed laboratory in Gaithersburg, Maryland, which also hosts the Clinical Laboratory Innovation Accelerator (CLIAx) to support overseas diagnostic startups. The OneTest for Cancer product is positioned as an affordable, accessible, and sensitive screening test, priced under $200, and designed for use with small volumes of capillary blood collected at home or retail locations. The company’s business model includes a 'funnel' approach where OneTest serves as an initial screening test, with follow-up testing by imaging or ctDNA-based tests for positive cases. The company also maintains a legacy business with BioCheck, a field test kit for screening suspicious powders for bioterror agents. The company has reagent supply contracts with Roche and Abbott to ensure supply chain stability. Financially, the company reported Q1 2026 revenue of $353,375 and a net loss of $2.17 million, with liquidity ratios indicating a current ratio of 1.82 and cash ratio of 1.64 as of March 31, 2026. Recent developments include a Q1 revenue decline with anticipated Q2 growth from a Maryland firefighter cancer screening program, a U.S. license secured for advanced chronic kidney disease prediction technology, and the launch of the Longevity blood test.

OMNIQ Corp. is a Delaware-based technology company that develops and delivers AI-driven machine vision solutions. Since shifting focus in 2014, OMNIQ has grown through acquisitions to become a provider of integrated hardware, software, and services for image processing and real-time surveillance. Its technology platform analyzes visual data from networked cameras to monitor vehicle and pedestrian activity across complex environments such as airports, campuses, municipalities, and transportation hubs. The company targets three main markets: public safety, hospitality, and supply chain management, offering solutions including license plate recognition, vehicle monitoring, people counting, and face capture. OMNIQ’s sales teams are organized by industry and geography, supported by technical experts to facilitate integration and customer support. The company competes in a competitive market by providing comprehensive solutions and emphasizing data privacy and secure architecture.

Allegro MicroSystems, Inc. operates in the semiconductor industry, specializing in integrated circuits and sensor solutions primarily for automotive and industrial applications. The company’s product portfolio includes current sensor ICs and power and sensing solutions. A large portion of its revenue is derived from automotive industry suppliers, making it sensitive to automotive market conditions and cyclicality. Allegro relies on a limited number of third-party wafer fabrication partners and suppliers, which introduces supply chain risks, especially amid recent export restrictions on critical materials. The company faces intense competition from larger semiconductor firms with significant resources and AI-driven product development capabilities. Allegro has experienced net losses in recent fiscal periods but maintains strong liquidity. Management changes and strategic initiatives, including acquisitions, are part of its growth approach.

Starco Brands, Inc. is a publicly traded company on the OTC Markets Group OTCQB tier under the ticker STCB. It is incorporated in Nevada with headquarters in Los Angeles, California. The company operates in the consumer products space, focusing on branded consumer goods and has taken steps toward vertical integration through acquisition of The Starco Group. Financial disclosures indicate revenues of over $31 million in mid-2024 and a net loss in early 2026. Liquidity metrics as of Q1 2026 show current liabilities slightly exceeding current assets. The company has secured a bridge loan to address debt and working capital needs. Legal proceedings include contract disputes with Global Brands, Ltd. and Nesco Resource, LLC, with outcomes currently indeterminate. The company is classified as a smaller reporting company and provides risk factor disclosures primarily in its annual filings.

Digital Brands Group, Inc. is a publicly traded company on the Nasdaq Capital Market, incorporated in Nevada and headquartered in Austin, Texas. The company operates in the apparel sector, focusing on private label manufacturing and marketing related to university student-athlete name, image, and likeness (NIL) programs. It has entered into material agreements with entities such as The Grove Collective, LLC and Athlete Capital Sports LLC to support apparel manufacturing and consulting services for NIL initiatives. The company has undertaken debt restructuring involving warrant exercises and new warrant issuances. Financially, as of March 31, 2026, the company reported cash and equivalents of approximately $5.12 million, current assets of $19.34 million, current liabilities of $26.84 million, a current ratio of 0.72, and a net loss of $11.39 million for the quarter [S1][S2][S12][S13][S14].

Charlie's Holdings, Inc. is a company engaged in the development, marketing, and sale of nicotine, synthetic nicotine, and alternative vapor products. The company does not have internal manufacturing capabilities and depends on third-party contract manufacturers for production. It has submitted regulatory applications to the FDA for its products and is involved in ongoing legal and regulatory proceedings related to these submissions. The company operates in a highly regulated and competitive market, with significant exposure to regulatory changes, competition from larger tobacco and vapor companies, and operational risks including supply chain and cybersecurity challenges.

AEVEX Corp. is a publicly traded aerospace and defense company specializing in unmanned aerial systems and related engineering services. The company completed its IPO in April 2026 and operates primarily in the U.S. defense sector. AEVE's business includes autonomous systems, launched effects, unmanned platforms, and additive manufacturing capabilities. It has established strategic partnerships, including joining Persistent Systems' Wave Relay® Ecosystem, enhancing its communications technology offerings. The company recently secured a significant contract with the U.S. Air Force, reflecting its role as a defense contractor.

Bayview Acquisition Corp is a Cayman Islands exempted blank check company formed in February 2023 to pursue a business combination with one or more businesses, primarily focusing on Asia. The company completed its IPO in December 2023, raising $60 million, and has since been identifying suitable acquisition targets. It has no operating revenues and generates non-operating income from interest on IPO proceeds held in trust. The company entered into a merger agreement with Oabay Inc., a Cayman Islands exempted company, to form a publicly traded enterprise trade credit digital transformation solutions company. The merger agreement has been amended multiple times, with the latest extension of the closing date to December 19, 2026. The company faced Nasdaq listing deficiencies related to minimum market value and shareholder meeting requirements but successfully appealed to continue listing on The Nasdaq Capital Market as of April 2026, with conditions including closing the business combination by June 19, 2026. As of March 31, 2026, the company had limited liquidity and reported a net loss for the quarter. The management team comprises experienced professionals in financial services, accounting, legal, and operations, focusing on identifying acquisition opportunities and creating shareholder value through operational improvements and growth strategies.

Barnwell Industries Inc. is an oil and gas company that has recently focused its operations by divesting non-core assets such as Water Resources International, Inc. The company has reported declining revenues and increasing losses in recent quarters, reflecting operational and market challenges. Governance issues have been prominent, including a proxy contest and shareholder activism. Liquidity metrics as of Q2 2026 indicate moderate short-term financial stability.

Dalrada Technology Group, Inc. is a diversified holding company with subsidiaries operating in specialty pharmacy (Genefic), climate technology (Dalrada Climate Technology), precision manufacturing, and technology services. The company generates revenue through these subsidiaries, with recent activity including construction projects and product commercialization. Dalrada has reported consistent net losses and working capital deficits, raising concerns about liquidity and going concern status. The company is actively engaged in legal disputes related to contracts and business relationships. It has established credit agreements to support liquidity and is pursuing growth through expansion of subsidiaries and new contracts, including international footprint expansion.

e.l.f. Beauty, Inc. operates as a multi-brand beauty company offering inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skincare products. The company’s mission is to make the best of beauty accessible to every eye, lip, and face. Its brand portfolio includes flagship e.l.f. Cosmetics, e.l.f. SKIN, rhode, Naturium, and Well People. The company distributes products through a combination of domestic mass-market retailers, specialty retailers, and e-commerce platforms, with a significant presence in the United States and international markets such as the UK, Canada, and Germany. e.l.f. Beauty emphasizes community-led innovation, premium quality at accessible prices, and a digitally focused marketing strategy targeting younger consumers. The company maintains strong relationships with major retail customers including Target, Walmart, Amazon, and Sephora. Its supply chain is asset-light and diversified across multiple countries, supported by third-party logistics providers. As of March 31, 2026, e.l.f. Beauty employed 849 full-time employees and maintains a high employee engagement culture. The company is committed to sustainability and social impact initiatives across its operations.

Critical Metals Corp. operates in the rare earth and critical metals mining sector, focusing on exploration, development, and acquisition of assets such as the Tanbreez project in Greenland. The company has increased its ownership in Tanbreez to 92.5% and is actively developing the project with technological deployments like autonomous drone systems. It has entered into a joint venture to build a rare earth processing facility in partnership with a Saudi Arabian conglomerate, aiming to support the U.S. defense supply chain. Additionally, Critical Metals has agreed to acquire European Lithium Ltd. through a share-based transaction, subject to regulatory and shareholder approvals. The company completed a PIPE financing in April 2026 to raise capital. Financially, the company reported a net loss and modest revenue for the fiscal year ending December 31, 2025, with liquidity ratios indicating current liabilities exceed current assets.

CFN Enterprises Inc. is a consumer brand platform primarily focused on the wine and beverage sector, operating through subsidiaries such as J Street Capital Partners, an importer and wholesaler of wines and alcoholic beverages, and Prestige Worldwide Wine Company, a winemaking consulting firm. The company also operates CFN Media, a digital marketing agency specializing in advertising for the cannabis, hemp, and wellness industries. The company has recently expanded its wine and beverage operations through acquisitions and the formation of Interstice Cellars LLC, a specialty wine developer and retailer. It discontinued its hemp manufacturing subsidiary Ranco LLC due to federal legislation banning intoxicating hemp-derived consumable products. The company faces extensive regulation in both its wine and cannabis-related businesses and competes with established players in these fragmented markets. Financially, the company has a history of losses, substantial indebtedness, and a working capital deficit as of the latest reporting period.

Chilean Cobalt Corp. is a critical minerals exploration and development company focused on cobalt and copper projects in northern Chile's San Juan District, including the La Cobaltera and El Cofre projects. The company operates through its wholly-owned subsidiary Baltum Mineria SpA and holds 6,377 hectares of mining concessions. It aims to develop cobalt and copper resources to supply markets driven by lithium-ion battery demand and electrification. The company also has an option to acquire rare earth element projects in southern Chile. Chilean Cobalt has established strategic partnerships with Glencore and US Strategic Metals to create an Americas-centric supply chain for cobalt and copper concentrates. The company is advancing ESG initiatives and governance frameworks and is evaluating a potential uplisting to a national securities exchange. Operations to date have been funded through equity and debt financing, with no revenues generated yet. The company faces typical early-stage mining development risks and is dependent on securing additional capital for continued operations and project development [S1,S2].

American Fusion, Inc. is a Texas-based corporation focused on the development of advanced fusion energy technologies through its wholly owned subsidiary, Kepler Fusion Technologies Inc. The company completed a reverse merger with Kepler in February 2026, with Kepler treated as the accounting acquirer. Post-merger, Kepler's former shareholders hold approximately 89.7% of the voting rights. The company changed its name from Renewal Fuels, Inc. to American Fusion, Inc. in March 2026. The business is in an early development stage with limited operating history and no reported revenue. The company has incurred recurring losses and has a significant accumulated deficit. It also has liquidity challenges, with current liabilities exceeding current assets as of March 31, 2026. The company has entered into consulting agreements with its CEO and advisors and has launched a Government Procurement Services segment supporting a Canadian defense procurement requirement, which is separate from its core fusion energy development activities.

Intuit Inc is a technology company operating in the software application industry, providing financial management and tax preparation software and services. Its business segments include Global Business Solutions, Consumer, and ProTax, serving small and mid-market businesses as well as individual consumers. The company offers platforms such as QuickBooks, Mailchimp, and TurboTax, with revenues derived from subscription services, software sales, and connected services. Intuit maintains strong liquidity and capital resources, supported by cash reserves and credit facilities. The company actively manages share repurchases and adapts its operations to incorporate artificial intelligence technologies.

iQSTEL Inc is a publicly traded company on the Nasdaq Capital Market under the ticker IQST. The company operates in sectors including AI, digital services, fintech, cybersecurity, and digital health, as outlined in a May 2026 corporate presentation. iQSTEL reported quarterly revenue of approximately $97.9 million for Q1 2026, with a net loss of about $1.39 million and a diluted EPS of -$0.29. The company maintains a current ratio near 1.0, indicating near parity between current assets and liabilities, and holds cash and equivalents of approximately $2.6 million. In April 2026, iQSTEL entered into an equity purchase agreement allowing it to raise up to $50 million through common stock sales. Recent news coverage highlights margin improvements, preliminary revenue milestones, and a Nasdaq uplisting with ambitions to reach $1 billion in revenue. Analyst coverage includes reiterated buy recommendations. The company is classified as a smaller reporting company and is not a shell company.

Splash Beverage Group, Inc. operates in the beverage industry, focusing on branded beverage products. The company is headquartered in Fort Lauderdale, Florida, and is publicly traded on the NYSE American exchange under the ticker SBEV. The company has a board of five independent directors and key executive officers including a President and Chief Marketing Officer and an Interim Chief Financial Officer. Splash Beverage Group has been actively expanding its product distribution channels, including a recent expansion of its Pulpoloco Sangria brand with Total Wine & More. The company reported modest revenue in Q1 2026 alongside a net loss and faces liquidity constraints as reflected in its low current and cash ratios. The company has outstanding debt obligations and related party advances, with ongoing negotiations regarding loan repayment demands. Governance policies include a code of ethics and a clawback policy for incentive compensation. The company has received multiple buy recommendations from financial analysts in recent months.

Jaguar Health, Inc. operates in the biopharmaceutical sector, focusing on gastrointestinal health products for both human and animal markets. The company’s lead human prescription drug, Mytesi, is approved for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar Health also markets Canalevia-CA1, a conditionally approved prescription drug for chronic idiopathic diarrhea in dogs. The company has licensed exclusive commercialization rights for these products in the United States to Woodward Specialty LLC, which is its primary revenue source. Jaguar Health has expanded its animal health portfolio with the launch of Neonorm Dog, a product aimed at companion animal gut health. The company is also integrating AI technology to enhance development and treatment applications of crofelemer, the active pharmaceutical ingredient in Mytesi. Jaguar Health’s operations include research and development, manufacturing through third-party contract manufacturers, and sales and marketing activities. The company faces challenges related to limited operating history, ongoing losses, liquidity constraints, and regulatory and supply chain risks. It has undertaken multiple reverse stock splits to maintain Nasdaq listing compliance and continues efforts to meet listing standards.